Fwd: Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer

---------- Forwarded message ----------
From: Connotea: Bookmarks matching tags breast and cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer
To: mesothelioma77@gmail.com


[1]

[2]Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer

Anna Storniolo et al.

Journal of Clinical Oncology 26 (20), (10 Jul 2008)

info:pmid/18490651 | info:doi/10.1200/JCO.2007.13.5202

Posted by [3]maverickny to [4]lapatinib [5]herceptin [6]combination [7]breast [8]cancer on [9]Wed Jul 16 2008 at 11:21 UTC | [10]info | related

maverickny

___
Source: http://www.connotea.org/user/maverickny/uri/5d52cc4b55959a7c735b0636be457a0b
--
 ~
Powered by [14]RssFwd, a service of [15]Blue Sky Factory, Inc